Your Location:
Home >
Browse articles >
Exploring Potential Biomarkers of Blood Stasis Syndrome in Coronary Heart Disease and Association Between Platelet Metabolic Disorder and Myocardial Injury Based on Platelet Metabolomics
Updated:2026-08-06
    • Exploring Potential Biomarkers of Blood Stasis Syndrome in Coronary Heart Disease and Association Between Platelet Metabolic Disorder and Myocardial Injury Based on Platelet Metabolomics

      Enhanced Publication
    • ZHAO Yanzhen , BAI Siyang , JIAN Weixiong , ZHOU Manli
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 17, Pages: 239-247(2026)
    • DOI: 10.13422/j.cnki.syfjx.20260661     

      CLC:
    • Revised:2026-05-24

      Accepted:01 June 2026

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 3 ) Tabs( 1 )

  • References

  • Publication Info

  • Metrics

75

Views

51

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Xuefu Zhuyutang Treats Coronary Heart Disease with Blood Stasis Syndrome in Rats via SIRT3 Signaling Pathway-mediated Regulation of Endothelial Function
Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics
Platelet Metabolomics Analysis in Rats of Coronary Heart Disease with Blood Stasis Syndrome by Overexpression of Fibrinogen
Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway
Mechanism of Wumeiwan on Inhibiting Fatty Acid Metabolism Reprogramming in Prevention and Treatment of Colorectal Cancer Based on Multi-omics Analysis

Related Author

YAN Qing
YU Yonghong
TIAN Peng
SU Chang
LIANG Hao
YANG Yang
PENG Qinghua
ZHANG Qiuyan

Related Institution

Hunan University of Chinese Medicine
Hunan Provincial Center for Drug Evaluation and Adverse Drug Reaction Monitoring
School of Clinical Medicine,Beijing University of Chinese Medicine
Beijing Key Laboratory of Chinese Materia Pharmacology,National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases,Institute of Basic Medical Sciences, Xiyuan Hospital,China Academy of Chinese Medical Sciences
Natural History Museum of China